Literature DB >> 18585951

Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease?

Gwenaëlle Le Pen1, Laure Sonnier, Andreas Hartmann, Jean-Charles Bizot, Fabrice Trovero, Marie-Odile Krebs, Alain Prochiantz.   

Abstract

Engrailed1 is a developmental gene of the homeogene family that controls the survival of midbrain dopaminergic neurons throughout life. Since these neurons have been crucially implicated in Parkinson's disease (PD), transgenic mice lacking one En1 allele could be of particular interest for the development of an animal model for PD. We showed in En1+/- mice, some traits reminiscent of PD such as (1) a progressive loss of mesencephalic dopaminergic (DA) neurons, and (2) motor deficits, anhedonia, decreased social interactions and depression-like behaviours. Further validation is needed, but these first results suggest that En1+/- mice could provide a promising model for the study of PD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585951     DOI: 10.1016/j.parkreldis.2008.04.007

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  8 in total

Review 1.  Parkinson's Disease: Overview of Transcription Factor Regulation, Genetics, and Cellular and Animal Models.

Authors:  Ninuo Xia; Deborah E Cabin; Fang Fang; Renee A Reijo Pera
Journal:  Front Neurosci       Date:  2022-05-04       Impact factor: 5.152

2.  miR-124 regulates cell apoptosis and autophagy in dopaminergic neurons and protects them by regulating AMPK/mTOR pathway in Parkinson's disease.

Authors:  Xin Gong; Huiqing Wang; Yongyi Ye; Yugao Shu; Yongwen Deng; Xiaozheng He; Guohui Lu; Shizhong Zhang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 3.  En1 and Wnt signaling in midbrain dopaminergic neuronal development.

Authors:  Maria T M Alves dos Santos; Marten P Smidt
Journal:  Neural Dev       Date:  2011-05-10       Impact factor: 3.842

4.  Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.

Authors:  Maykel Cruz-Monteagudo; Fernanda Borges; Cesar Paz-Y-Miño; M Natália D S Cordeiro; Irene Rebelo; Yunierkis Perez-Castillo; Aliuska Morales Helguera; Aminael Sánchez-Rodríguez; Eduardo Tejera
Journal:  BMC Med Genomics       Date:  2016-03-09       Impact factor: 3.063

5.  Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.

Authors:  Ulrika Nordströma; Geneviève Beauvais; Anamitra Ghosh; Baby Chakrapani Pulikkaparambil Sasidharan; Martin Lundblad; Julia Fuchs; Rajiv L Joshi; Jack W Lipton; Andrew Roholt; Satish Medicetty; Timothy N Feinstein; Jennifer A Steiner; Martha L Escobar Galvis; Alain Prochiantz; Patrik Brundin
Journal:  Neurobiol Dis       Date:  2014-10-02       Impact factor: 5.996

6.  Otx2 Requires Lmx1b to Control the Development of Mesodiencephalic Dopaminergic Neurons.

Authors:  Orna Sherf; Limor Nashelsky Zolotov; Keren Liser; Hadas Tilleman; Vukasin M Jovanovic; Ksenija Zega; Marin M Jukic; Claude Brodski
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

Review 7.  Retrograde Axonal Degeneration in Parkinson Disease.

Authors:  Patricia Tagliaferro; Robert E Burke
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

Review 8.  Neuropsychiatric Disorders in Parkinson's Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?

Authors:  Kathy Dujardin; Véronique Sgambato
Journal:  Front Neurosci       Date:  2020-01-29       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.